Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Medulloblastoma cancer stem cells: molecular signatures and therapeutic targets.

Bahmad HF, Poppiti RJ.

J Clin Pathol. 2020 Feb 7. pii: jclinpath-2019-206246. doi: 10.1136/jclinpath-2019-206246. [Epub ahead of print]

PMID:
32034059
2.

Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier.

Bahmad HF, Chamaa F, Assi S, Chalhoub RM, Abou-Antoun T, Abou-Kheir W.

Front Mol Neurosci. 2019 May 27;12:131. doi: 10.3389/fnmol.2019.00131. eCollection 2019. Review.

3.

Medulloblastoma stem cells: Promising targets in medulloblastoma therapy.

Huang GH, Xu QF, Cui YH, Li N, Bian XW, Lv SQ.

Cancer Sci. 2016 May;107(5):583-9. doi: 10.1111/cas.12925. Epub 2016 Apr 27. Review.

4.

Sonic Hedgehog Medulloblastoma Cancer Stem Cells Mirnome and Transcriptome Highlight Novel Functional Networks.

Po A, Abballe L, Sabato C, Gianno F, Chiacchiarini M, Catanzaro G, De Smaele E, Giangaspero F, Ferretti E, Miele E, Besharat ZM.

Int J Mol Sci. 2018 Aug 8;19(8). pii: E2326. doi: 10.3390/ijms19082326.

5.

Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications.

Abou-Antoun TJ, Hale JS, Lathia JD, Dombrowski SM.

Neurotherapeutics. 2017 Apr;14(2):372-384. doi: 10.1007/s13311-017-0524-0. Review.

6.

Targeting therapy-resistant cancer stem cells by hyperthermia.

Oei AL, Vriend LEM, Krawczyk PM, Horsman MR, Franken NAP, Crezee J.

Int J Hyperthermia. 2017 Jun;33(4):419-427. doi: 10.1080/02656736.2017.1279757. Epub 2017 Feb 2.

PMID:
28100096
7.

Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells.

Lu KH, Chen YW, Tsai PH, Tsai ML, Lee YY, Chiang CY, Kao CL, Chiou SH, Ku HH, Lin CH, Chen YJ.

Childs Nerv Syst. 2009 May;25(5):543-50. doi: 10.1007/s00381-009-0826-6. Epub 2009 Feb 19.

PMID:
19225784
8.

Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.

Ahmed N, Escalona R, Leung D, Chan E, Kannourakis G.

Semin Cancer Biol. 2018 Dec;53:265-281. doi: 10.1016/j.semcancer.2018.10.002. Epub 2018 Oct 11. Review.

9.

Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells.

Chang CJ, Chiang CH, Song WS, Tsai SK, Woung LC, Chang CH, Jeng SY, Tsai CY, Hsu CC, Lee HF, Huang CS, Yung MC, Liu JH, Lu KH.

Childs Nerv Syst. 2012 Mar;28(3):363-73. doi: 10.1007/s00381-011-1672-x. Epub 2012 Jan 17.

PMID:
22249380
10.

Cancer stem cells: a new framework for the design of tumor therapies.

Garvalov BK, Acker T.

J Mol Med (Berl). 2011 Feb;89(2):95-107. doi: 10.1007/s00109-010-0685-3. Epub 2010 Oct 2. Review.

PMID:
20890588
11.

Therapeutic approaches targeting cancer stem cells.

Pan Y, Ma S, Cao K, Zhou S, Zhao A, Li M, Qian F, Zhu C.

J Cancer Res Ther. 2018;14(7):1469-1475. doi: 10.4103/jcrt.JCRT_976_17. Review.

12.

Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies.

Wang J, Garancher A, Ramaswamy V, Wechsler-Reya RJ.

Annu Rev Neurosci. 2018 Jul 8;41:207-232. doi: 10.1146/annurev-neuro-070815-013838. Epub 2018 Apr 11. Review.

PMID:
29641939
13.

Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.

Bassani B, Bartolini D, Pagani A, Principi E, Zollo M, Noonan DM, Albini A, Bruno A.

PLoS One. 2016 Jul 1;11(7):e0154111. doi: 10.1371/journal.pone.0154111. eCollection 2016.

14.

FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.

McClements L, Annett S, Yakkundi A, O'Rourke M, Valentine A, Moustafa N, Alqudah A, Simões BM, Furlong F, Short A, McIntosh SA, McCarthy HO, Clarke RB, Robson T.

BMC Cancer. 2019 Apr 11;19(1):351. doi: 10.1186/s12885-019-5500-0.

15.

Cancer stem cells as a potential therapeutic target in breast cancer.

Zhang M, Li Z, Zhang X, Chang Y.

Stem Cell Investig. 2014 Jul 16;1:14. doi: 10.3978/j.issn.2306-9759.2014.06.01. eCollection 2014. Review.

16.

Cancer stem cells, metabolism, and therapeutic significance.

Yang M, Liu P, Huang P.

Tumour Biol. 2016 May;37(5):5735-42. doi: 10.1007/s13277-016-4945-x. Epub 2016 Feb 10. Review.

PMID:
26864589
17.

Approaches for targeting cancer stem cells drug resistance.

Rosa R, D'Amato V, De Placido S, Bianco R.

Expert Opin Drug Discov. 2016 Dec;11(12):1201-1212. Epub 2016 Oct 14. Review.

PMID:
27700193
18.

PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.

Singh AR, Joshi S, Zulcic M, Alcaraz M, Garlich JR, Morales GA, Cho YJ, Bao L, Levy ML, Newbury R, Malicki D, Messer K, Crawford J, Durden DL.

PLoS One. 2016 Mar 3;11(3):e0150836. doi: 10.1371/journal.pone.0150836. eCollection 2016.

19.

Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?

Zhang Q, Feng Y, Kennedy D.

Cell Mol Life Sci. 2017 Mar;74(5):777-801. doi: 10.1007/s00018-016-2362-3. Epub 2016 Sep 12. Review.

PMID:
27622244
20.

Targeted therapy against cancer stem cells.

Yang T, Rycaj K.

Oncol Lett. 2015 Jul;10(1):27-33. Epub 2015 May 4.

Supplemental Content

Support Center